277 related articles for article (PubMed ID: 21436711)
1. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation.
Ellis CL; Ma ZM; Mann SK; Li CS; Wu J; Knight TH; Yotter T; Hayes TL; Maniar AH; Troia-Cancio PV; Overman HA; Torok NJ; Albanese A; Rutledge JC; Miller CJ; Pollard RB; Asmuth DM
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):363-70. PubMed ID: 21436711
[TBL] [Abstract][Full Text] [Related]
2. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
Schunter M; Chu H; Hayes TL; McConnell D; Crawford SS; Luciw PA; Bengmark S; Asmuth DM; Brown J; Bevins CL; Shacklett BL; Critchfield JW
BMC Complement Altern Med; 2012 Jun; 12():84. PubMed ID: 22747752
[TBL] [Abstract][Full Text] [Related]
3. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota in HIV-pneumonia patients is related to peripheral CD4 counts, lung microbiota, and in vitro macrophage dysfunction.
Shenoy MK; Fadrosh DW; Lin DL; Worodria W; Byanyima P; Musisi E; Kaswabuli S; Zawedde J; Sanyu I; Chang E; Fong S; McCauley K; Davis JL; Huang L; Lynch SV
Microbiome; 2019 Mar; 7(1):37. PubMed ID: 30857553
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.
Jiang W; Lederman MM; Hunt P; Sieg SF; Haley K; Rodriguez B; Landay A; Martin J; Sinclair E; Asher AI; Deeks SG; Douek DC; Brenchley JM
J Infect Dis; 2009 Apr; 199(8):1177-85. PubMed ID: 19265479
[TBL] [Abstract][Full Text] [Related]
6. Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
Dillon SM; Kibbie J; Lee EJ; Guo K; Santiago ML; Austin GL; Gianella S; Landay AL; Donovan AM; Frank DN; McCARTER MD; Wilson CC
AIDS; 2017 Feb; 31(4):511-521. PubMed ID: 28002063
[TBL] [Abstract][Full Text] [Related]
7. Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression.
Basilissi M; Tincati C; Merlini E; Ancona G; Borghi E; Borgo F; Barassi A; d'Arminio Monforte A; Marchetti G
PLoS One; 2019; 14(2):e0212075. PubMed ID: 30763359
[TBL] [Abstract][Full Text] [Related]
8. Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals.
Neff CP; Krueger O; Xiong K; Arif S; Nusbacher N; Schneider JM; Cunningham AW; Armstrong A; Li S; McCarter MD; Campbell TB; Lozupone CA; Palmer BE
EBioMedicine; 2018 Apr; 30():192-202. PubMed ID: 29650491
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.
Dinh DM; Volpe GE; Duffalo C; Bhalchandra S; Tai AK; Kane AV; Wanke CA; Ward HD
J Infect Dis; 2015 Jan; 211(1):19-27. PubMed ID: 25057045
[TBL] [Abstract][Full Text] [Related]
10. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals.
Xie Y; Sun J; Wei L; Jiang H; Hu C; Yang J; Huang Y; Ruan B; Zhu B
BMC Microbiol; 2021 Jan; 21(1):11. PubMed ID: 33407128
[TBL] [Abstract][Full Text] [Related]
11. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
[TBL] [Abstract][Full Text] [Related]
12. Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade.
SahBandar IN; Chew GM; Corley MJ; Pang APS; Tsai N; Hanks N; Khadka VS; Klatt NR; Hensley-McBain T; Somsouk M; Vujkovic-Cvijin I; Chow DC; Shikuma CM; Ndhlovu LC
AIDS; 2020 Aug; 34(10):1451-1460. PubMed ID: 32675558
[TBL] [Abstract][Full Text] [Related]
13. Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy.
Lewy T; Hong BY; Weiser B; Burger H; Tremain A; Weinstock G; Anastos K; George MD
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):276-286. PubMed ID: 29808701
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota from high-risk men who have sex with men drive immune activation in gnotobiotic mice and in vitro HIV infection.
Li SX; Sen S; Schneider JM; Xiong KN; Nusbacher NM; Moreno-Huizar N; Shaffer M; Armstrong AJS; Severs E; Kuhn K; Neff CP; McCarter M; Campbell T; Lozupone CA; Palmer BE
PLoS Pathog; 2019 Apr; 15(4):e1007611. PubMed ID: 30947289
[TBL] [Abstract][Full Text] [Related]
15. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
Serrano-Villar S; Sainz T; Ma ZM; Utay NS; Chun TW; Mann S; Kashuba AD; Siewe B; Albanese A; Troia-Cancio P; Sinclair E; Somasunderam A; Yotter T; Deeks SG; Landay A; Pollard RB; Miller CJ; Moreno S; Asmuth DM
PLoS Pathog; 2016 Jan; 12(1):e1005381. PubMed ID: 26795282
[TBL] [Abstract][Full Text] [Related]
16. HIV-induced immunosuppression is associated with colonization of the proximal gut by environmental bacteria.
Yang L; Poles MA; Fisch GS; Ma Y; Nossa C; Phelan JA; Pei Z
AIDS; 2016 Jan; 30(1):19-29. PubMed ID: 26731752
[TBL] [Abstract][Full Text] [Related]
17. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Anthelmintic Treatment on Human Gut Microbiota Based on Cross-Sectional and Pre- and Postdeworming Comparisons in Western Kenya.
Easton AV; Quiñones M; Vujkovic-Cvijin I; Oliveira RG; Kepha S; Odiere MR; Anderson RM; Belkaid Y; Nutman TB
mBio; 2019 Apr; 10(2):. PubMed ID: 31015324
[TBL] [Abstract][Full Text] [Related]
19. Alterations in bacterial communities, SCFA and biomarkers in an elderly HIV-positive and HIV-negative population in western Mexico.
González-Hernández LA; Ruiz-Briseño MDR; Sánchez-Reyes K; Alvarez-Zavala M; Vega-Magaña N; López-Iñiguez A; Díaz-Ramos JA; Martínez-Ayala P; Soria-Rodriguez RA; Ramos-Solano M; Andrade-Villanueva JF
BMC Infect Dis; 2019 Mar; 19(1):234. PubMed ID: 30845929
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the intestinal microbiota in MSM with HIV infection.
Fu Y; Ke S; Tang G; Guo Q; Guo Q; Wang Z; Leng R; Fan Y
BMC Microbiol; 2024 Jun; 24(1):192. PubMed ID: 38831399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
